CERT: Certara Corp Average Forecast Price

This daily price chart for Certara, Inc. (CERT) on the GURU.Markets platform reflects the asset's dynamics, with a value of 12.71. The business relies on the development of biosimulation software, yet remains vulnerable to pharmaceutical companies cutting innovation spending and slow deal closures. Global expansion is hindered by political pressure and divergent medical standards. The company minimizes its environmental footprint through the digitalization of testing and energy-efficient offices.

CERT: Certara Software Consensus Target 07/04/2022 - 11/11/2026

Certara Corp (CERT) - metric breakdowns and financial figures

- market price and analyst price targets:

Stock Quotes certara.com|CERT - Analyst Consensus Forecast

- market capitalization information:

Market Value Certara Corp|CERT - Total Company Value

- shareholders' equity book value data:

Accounting Value of a Share Certara|CERT - Company Net Assets|Market Cap to Book Value Multiple certara.com|CERT - Company Total Assets

- issuer credit burden and liquidity indicators:

- earnings and valuation multiples information:

CERT - Net Profit|Net Profit Forecast Certara, Inc.|CERT - P/E Multiple|Projected Price to Earnings Certara Inc|CERT - PEG Multiple|Company Value to EBITDA Certara Corp|CERT - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Certara|CERT - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months certara.com|CERT - Earnings growth in current year|Earnings growth forecast for next year Certara, Inc.

Summary company analytics:certara.com, CERT

Assessing the operational strength of assets begins with an analysis of market expectations. Certara, Inc. (CERT) optimizes drug development through biosimulation software, increasing the efficiency of R&D cycles. The consensus target price aggregates average expert valuations, reflecting the balance between supply and demand. This chart's price action reveals either fundamental business growth or excess liquidity. The stability of these forecasts confirms the resilience of the company's business model within the healthcare sector.

Competitors of Certara, Inc.